Eyebot - Market Research Report

Self-Serve Vision Testing Kiosks for Accessible Eye Care

Report Date: September 2025

Market Position

Strong Growth Potential

Executive Summary

Key Findings

Global vision care market projected to reach $113B by 2032
Eyebot's 90-second vision test is fastest in market
$20M Series A funding led by General Catalyst
Strong B2B/B2C hybrid business model
Physical kiosk presence in high-traffic locations

Market Opportunities

Expansion into retail, pharmacy, and university locations
Partnerships with healthcare providers and insurers
Technology enhancement for new features (e.g., diabetic retinopathy screening)
Brand building and marketing for consumer trust

Company Overview

Founded:2021

Location:Boston, MA

Legal Entity:Eyebot, Inc.

Website:https://www.eyebot.co/

Industry:Vision Care, Health Tech

Stage:Series A

Team Size:20+ (2025)

Eyebot is a Boston-based technology company revolutionizing vision care with its self-serve vision testing kiosks. Founded in 2021, Eyebot's mission is to make vision care accessible and affordable for everyone. The company has developed a 90-second vision test kiosk that delivers doctor-verified glasses prescriptions, eliminating traditional barriers such as appointment delays and insurance complexity. Eyebot operates a hybrid B2B/B2C model, leasing kiosks to retailers and providing free vision tests to consumers, with results reviewed by licensed eye doctors. With $20M Series A funding led by General Catalyst, Eyebot is rapidly expanding its kiosk network and team, targeting malls, universities, retail stores, pharmacies, and airports nationwide.

Report Feedback

Your feedback helps us improve our research reports and better serve our community.